Category: Drug Discovery
Drug Discovery market research reports by GlobalData
-
Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in CLBP therapeutics. There will be more than 344 million prevalent cases of CLBP in 202 ... Read More
-
Alzheimer’s Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030
Alzheimer’s Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030 Summary This report covers the 8mm (US, France, Germany, Italy, Spain, UK, Japan, China) and provides an ... Read More
-
Rhabdomyosarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Rhabdomyosarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Rhabdomyosarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, S ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial S ... Read More
-
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PsA therapeutics. There will be more than 6 million prevalent cases of PsA in 2023 in th ... Read More
-
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in BDD therapeutics. There will be 67,698,071 total prevalent cases of BDD in 2023 in ... Read More
-
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis - Global Clinical Trials Review, 2023 provides an overview of A ... Read More
-
Future of Pharma - Looking Ahead to 2023
Future of Pharma - Looking Ahead to 2023 Summary This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and mar ... Read More
-
Obsessive-Compulsive Disorder (OCD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Obsessive-Compulsive Disorder (OCD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive There will be more than 96,921,887 diagnosed prevalent cases of OCD in 2023 in the 16 major ... Read More
-
Myelofibrosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031
Myelofibrosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031 Summary This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and China) and includes an as ... Read More
-
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial S ... Read More
-
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis (NASH) Clinical Trial Analysis by Trial Phase, Trial Sta ... Read More
-
Angelman Syndrome (AS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Angelman Syndrome (AS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AS therapeutics. There will be more than 313,981 diagnosed prevalent cases of AS in 2023 in ... Read More
-
Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031
Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031 Summary Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by chronic inflammation and ulcers (sores) in the large intestine, also called the colon and rectum. The inflammation usually begins in the rectum and ... Read More
-
Essential Tremor (ET) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Essential Tremor (ET) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in ET therapeutics. There will be more than 6,000,000 diagnosed prevalent cases of ET in 2023 i ... Read More
-
Cellulitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Cellulitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Cellulitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type ... Read More
-
Mycosis Fungoides Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Mycosis Fungoides Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Mycosis Fungoides Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, ... Read More
-
Glaucoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Glaucoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Glaucoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and ... Read More
-
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in bladder cancer therapeutics. Synopsis In 2022, there will be more than 460,000 diagnosed incident c ... Read More
-
Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029
Type 2 Diabetes Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029 Summary Type 2 Diabetes Mellitus, or T2D for short, refers to a defect in insulin secretion and sensitivit ... Read More
-
Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in SIT therapeutics. Synopsis In 2022, more than 26.9 million diagnosed inciden ... Read More
-
Liver Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Liver Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Liver Fibrosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Spon ... Read More
-
Peripheral Artery Occlusive Disease (PAOD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Peripheral Artery Occlusive Disease (PAOD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Peripheral Artery Occlusive Disease (PAOD) Clinical Trial Analysis by Trial Pha ... Read More
-
Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trial Analysis by Trial Phase ... Read More
-
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in CIDP therapeutics. Synopsis In 2022, there will be more t ... Read More
Research Assistance
